However, in a PV case–control study conducted by Segura-Díaz et al. [13], TET2 mutation was significantly associated with thrombotic events, and patients with TET2 mutations had a significantly higher risk of thrombosis. This evidence concerns the gene TET2 and acquired polycythemia vera.